GlassScriptPhysician profile
Theodore P Felderman
NPI 1710940622
$4,914.36
in general payments reported to CMS, 2019-2025
13 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2022: $15.88 · 2023: $496 · 2024: $4,056 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,270 · Food and Beverage: $976 · Travel and Lodging: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,270.00 |
| Food and Beverage | $975.66 |
| Travel and Lodging | $405.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $4,234.68 | 2019-2024 | Erleada, Akeega |
| Dendreon Pharmaceuticals LLC | $197.35 | 2023 | Provenge |
| Astellas Pharma US INC | $151.83 | 2019-2024 | Xtandi |
| Urogen Pharma, INC. | $100.00 | 2025 | |
| Merck Sharp & Dohme LLC | $48.16 | 2023 | |
| Amgen INC. | $39.40 | 2019 | |
| Ferring Pharmaceuticals INC. | $34.92 | 2019 | |
| Janssen Scientific Affairs, LLC | $19.78 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.99 | 2019 | |
| Antares Pharma, INC. | $18.74 | 2019 | |
| Civco Medical Instruments | $18.32 | 2024 | |
| Endo Pharmaceuticals INC. | $16.31 | 2019 | |
| Celgene Corporation | $15.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Felderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.